{
    "N/R/U": null,
    "Applicant": "Merck Sharp & Dohme LLC",
    "BLA Number": "125126",
    "Proprietary Name": "Gardasil",
    "Proper Name": "Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant",
    "BLA Type": "351(a)",
    "Strength": "120MCG L1 PROTEIN FROM HPV 6, 11, 16 AND 18 UG/.5ML",
    "Dosage Form": "Injection",
    "Route of Administration": "Intramuscular",
    "Product Presentation": "Syringe",
    "Marketing Status": "Disc",
    "Licensure": "Licensed",
    "Approval Date": "8-Jun-06",
    "Ref. Product Proper Name": " ",
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "0",
    "Submission Type": "Original",
    "License Number": "2",
    "Product Number": "1",
    "Center": "CBER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null
}